Technology | October 07, 2013

Claron to Debut Enhanced Modality Support for Nil Universal Viewers

remote viewing system rsna 2013 claron nil universal viewer nilread

October 7, 2013 — Claron Technology will announce extended modality support for its Nil universal zero-footprint medical viewers at the Radiological Society of North America (RSNA) 2013 conference. The Nil viewer family includes NilShare, optimized for enterprise viewing, and NilRead, newly U.S. Food and Drug Administration (FDA)-cleared for diagnostic use. Also new at RSNA is support for high-definition MPEG-4 videos as well as all common image formats including JPEG, TIFF and PNG. The viewers now support full cross-enterprise document sharing (XDS), integrating healthcare enterprise (IHE) profiles, including comprehensive health level 7 (HL7) clinical document architecture (CDA) documents. The Nil viewer family is optimized for cache-less integration with remote archives, including picture archiving and communication systems (PACS) and vender neutral archives (VNA), streaming data without caching it. This allows Nil to provide the best user experience for the clinical workflow typical of universal viewers, where it is not possible to optimize data access based on a scheduled workflow.

For more information: www.clarontech.com

Related Content

Ambra Health Launches Mobile App for Instant Medical Image Access
Technology | Mobile Devices | November 09, 2018
Ambra Health announced the launch of its first iOS mobile app for healthcare providers and patient access. Designed...
Feature | PET Imaging | November 07, 2018 | By Greg Freiherr
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology....
Podcast | PET Imaging | November 07, 2018
PET is getting ready to venture outside oncology, cardiology and mainstream neurology.
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Fujifilm SonoSite Launches New Point-of-Care Ultrasound Educational Resources
News | Ultrasound Imaging | November 01, 2018
Fujifilm SonoSite Inc. announced the launch of its redesigned SonoSite Institute, a comprehensive online educational...
Vygon and Sonoscanner Partnering on New Ultrasound System for Catheter Placement Guidance
News | Cardiovascular Ultrasound | October 31, 2018
Vygon, an international group specialized in single-use medical devices, and French company Sonoscanner announced the...
Carestream Spotlights Healthcare IT and Imaging Systems at RSNA 2018
News | Information Technology | October 31, 2018
Carestream announced it will be displaying several imaging and healthcare information technology (IT) offerings at the...
Cardiac Ultrasound Software Streamlines Fetal Heart Exams
Feature | Cardiovascular Ultrasound | October 30, 2018
A new tool called fetalHQ on GE Healthcare’s Voluson ultrasound systems is the first tool to simultaneously examine the...
Hitachi Supports ASE Foundation Cardiovascular Outreach Mission in West Virginia
News | Cardiovascular Ultrasound | October 29, 2018
Hitachi Healthcare Americas participated in the cardiovascular screening and diagnostic triage event that took place...
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....